Padmaja Magadala

539 citations
5 papers · 393 indexed · h-index 4
Topics
Chronic Lymphocytic Leukemia Research (4 papers)Monoclonal and Polyclonal Antibodies Research (3 papers)Lymphoma Diagnosis and Treatment (3 papers)
Partner nations
United StatesNetherlands

In The Last Decade

Padmaja Magadala

5 papers receiving 386 citations

Peers

Padmaja Magadala
Comparison fields: 5 of 46
  • Genetics 258
  • Pathology and Forensic Medicine 186
  • Immunology 153
  • Molecular Biology 97
  • Oncology 96
Replace Priscilla Do with:
Priscilla Do United States
Petra Vočková Czechia
Sarah Haebe Germany
Lucy Gong United States
Nele Fourneau United States
Stefano Baldoni Italy
Andrei Ivanov Russia
JW Uhr United States
Huangming Hong China
Kevin O’Boyle United States
Padmaja Magadala relative to Priscilla Do United States Priscilla Do's profile →
Citations per field
00.5×4.6×
Priscilla Do · 1×
Citations per year

Countries citing papers authored by Padmaja Magadala

Since Specialization
Citations

This map shows the geographic impact of Padmaja Magadala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Padmaja Magadala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Padmaja Magadala more than expected).

Fields of papers citing papers by Padmaja Magadala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Padmaja Magadala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Padmaja Magadala. The network helps show where Padmaja Magadala may publish in the future.

Co-authorship network of co-authors of Padmaja Magadala

This figure shows the co-authorship network connecting the top 25 collaborators of Padmaja Magadala. A scholar is included among the top collaborators of Padmaja Magadala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Padmaja Magadala. Padmaja Magadala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 159
2 3
3 174
4 5
5 52

About Padmaja Magadala

Padmaja Magadala is a scholar working on Genetics, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging, having authored 5 papers that have together received 393 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Genetics (258 citations), Pathology and Forensic Medicine (186 citations) and Immunology (153 citations). Padmaja Magadala has collaborated with scholars based in United States and Netherlands. Frequent co-authors include Michelle Francesco, Min Huang, Betty Chang, Joseph J. Buggy, Mansoor M. Amiji, William H. Robinson, Jeremy Sokolove, Jun Chen, Annemieke Kuil and Susanne Steggerda. Their work appears in journals such as Blood, Cancer Research and Arthritis Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026